Cargando…
The effect of morning versus evening administration of empagliflozin on its pharmacokinetics and pharmacodynamics characteristics in healthy adults: a two-way crossover, non-randomised trial
Background: Empagliflozin is an SGLT2 inhibitor approved for use in patients with diabetes mellitus type 2 (DMT2) with or without other cardiovascular disease. Empagliflozin is taken once daily without rationale on the optimal timing for administration. This study aimed to determine the chronopharma...
Autores principales: | ElDash, Rana M., Raslan, Mohamed A., Shaheen, Sara M., Sabri, Nagwa Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167502/ https://www.ncbi.nlm.nih.gov/pubmed/34123370 http://dx.doi.org/10.12688/f1000research.51114.1 |
Ejemplares similares
-
Changes in the Pharmacokinetics and Pharmacodynamics of Sildenafil in Cigarette and Cannabis Smokers
por: Murtadha, Mohammed, et al.
Publicado: (2021) -
Morning and evening exercise
por: Seo, Dae Yun, et al.
Publicado: (2013) -
Time of administration important? Morning versus evening dosing of valsartan
por: Zappe, Dion H., et al.
Publicado: (2015) -
The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: A randomised comparison
por: Prayle, A.P., et al.
Publicado: (2016) -
On the Comparative Frequency of the Morning and Evening Pulse
por: Stratton, Thomas
Publicado: (1843)